The company's pharma growth strategy advances with regulatory filings for key therapies, Phase III successes in oncology and radiology, and progress in gene therapy and precision oncology.
Fraunhofer IPMS micro scanners offer high-resolution imaging for endoscopes, microscopy, and spectroscopy, with stable performance and innovative 2D vector scanners enabling faster, precise medical imaging.
Effective immediately, ALBIS will distribute Arkema's medical range of Pebax MED thermoplastic elastomers, Rilsan MED polyamide 11, Rilsamid MED polyamide 12, Rilsan MED Clear transparent polyamide, and Kynar MED PVDF.
The REGENERATE-PD trial uses randomization and a double-blind design to evaluate AB-1005's efficacy and safety in treating moderate-stage Parkinson’s Disease, minimizing bias.
At CES 2025, RealMan highlighted a suite of cutting-edge products designed to revolutionize multiple sectors, from retail and healthcare to industrial and domestic applications.
Kollmorgen's SMM2.0 firmware upgrade expands compatibility to more encoder and motor types, simplifying compliance with EU functional safety standards and supporting applications in food processing and material forming.
Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.
Developed by Fraunhofer ISC's SUSI project, the scalable suspension bioreactor will be used for long-term hiPSC culturing, optimizing temperature, CO2 levels, mixing, and shear forces for reproducibility.
The partnership will integrate bioreactors with MAVEN, enabling automated, real-time glucose and lactate monitoring in cell cultures for continuous process control without manual sampling.